ICICI Securities Ltd | Retail Equity Research Revenues increased 18% YoY to | 4436 crore (I-direct estimate: | 4189 crore) mainly due to strong growth in the US and Europe. The US revenue grew 21% YoY to | 2099 crore (I-direct estimate: | 1957 crore) mainly due to launched of limited competition product Sevelamer carbonate (nephrology). Europe revenues grew 37% YoY to | 1114 crore (I-direct estimate: | 997 crore). EBITDA margins improved 58 bps YoY to 25.2% (I-direct estimates:...